| Literature DB >> 11095772 |
.
Abstract
Fungi, both endemic and opportunistic, continue to be recognized as increasingly frequent pulmonary pathogens. Better appreciation of their epidemiology and clinical course, as well as clarification of the roles of the newer triazoles and lipid formulations of amphotericin B in treatment, have occurred within the past few years. Both endemic and opportunistic fungal pulmonary pathogens are reviewed, with emphasis on recent therapeutic advances.Entities:
Year: 1999 PMID: 11095772 PMCID: PMC7102184 DOI: 10.1007/s11908-999-0015-5
Source DB: PubMed Journal: Curr Infect Dis Rep ISSN: 1523-3847 Impact factor: 3.725